| Antibodies - Study reveals why COVID-19 antibodies fade quickly |
|
|
|
|
| |
|
|
| |
The latest antibodies news from News Medical |
|
|
|
 | | |
 Exploring Tissue Fixation and Downstream Analysis
The use of biospecimens is common in research, from initial research stages to late-phase clinical trials. As a result, a comprehensive understanding of pre-analytical deviations in collection, processing, and storage is vital to downstream applications and data analysis. This article from BioIVT explains how tissue fixation influences downstream analysis.
| |
|
|
|
|
| | |  The potential of COVID-19 booster vaccine products (antibodies) passed from mother to offspring through breastmilk. | | | | |  Mayo Clinic scientists have developed an immunotherapy strategy that potentially lays the groundwork for treating a spectrum of autoimmune diseases. | | | | |  Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working. | | | | |  Researchers review milk ladder use for managing cow's milk allergy in children, emphasizing its potential in safely introducing cow's milk to induce tolerance and the need for standardization and further research. | | | | |  Researchers unveil the complex cellular architecture of the heart using advanced RNA sequencing and imaging techniques, shedding light on the intricate organization of heart cells and their developmental pathways. | | | | |  Breakthrough in Brain Cancer Treatment: Dual-Target CAR T Cell Therapy Shows Promise in Early Clinical Trial. | |
|
|
|
|
| | | How would you rate today's newsletter?
| |
|
|
|
|
|
